中国小儿急救医学
中國小兒急救醫學
중국소인급구의학
CHINESE PEDIATRIC EMERGENCY MEDICINE
2014年
8期
508-512,516
,共6页
项龙%张建%任宏%钱娟%李璧如%王莹%胡肖伟
項龍%張建%任宏%錢娟%李璧如%王瑩%鬍肖偉
항룡%장건%임굉%전연%리벽여%왕형%호초위
高频振荡通气%急性低氧性呼吸衰竭%急性呼吸窘迫综合征%儿童
高頻振盪通氣%急性低氧性呼吸衰竭%急性呼吸窘迫綜閤徵%兒童
고빈진탕통기%급성저양성호흡쇠갈%급성호흡군박종합정%인동
High-frequency oscillatory ventilation%Acute hypoxemic respiratory failure%Acute respiratory distress syndrome%Children
目的 评估儿童急性低氧性呼吸衰竭(acute hypoxemic respiratory failure,AHRF)给予高频振荡机械通气(high-frequency oscillatory ventilation,HFOV)治疗的意义.方法 回顾2011年1月至2013年9月收入我院PICU诊断为AHRF的病例,首先给予常规机械通气(CMV),当PIP> 30cmH2O(1 cmH2O =0.098 kPa)或PEEP> 10 cmH2O、FiO2100%时具有以下情况之一:(1)SpO2 <90%或PaO2 <60 mmHg(1 mmHg =0.133 kPa);(2)有严重呼吸性酸中毒(PaCO2> 80mmHg);(3)严重气漏(纵隔气肿或气胸),改为HFOV通气治疗.收集患儿性别、年龄、住PICU时间、CMV通气时间、HFOV通气时间等一般资料.分别于CMV通气末(H0)及HFOV后2 h(H2)、6 h(H6)、12 h(H12)、24 h(H24)、48 h(H48)记录并比较各时间点呼吸机参数(平均气道压、振幅、频率、FiO2)、氧合指数(PaO2/FiO2、OI)、动脉血气、心率、血压变化.分别比较存活组与死亡组、血液肿瘤组及非血液肿瘤组在H0、H2、H6、H12、H24、H48时间点的指标变化.结果 HFOV通气后,H2时间点PaO2较H0升高[76.9(61.9~128.0) mm-Hg vs 50.1 (49.5 ~ 68.0) mmHg],差异有统计学意义(P=0.006).H2、H48时间点PaO2/FiO2分别较Ho、H24升高,差异有统计学意义[94.9(66.8 ~ 138.9) mmHg vs 68.0(49.5 ~ 86.8)mmHg,P=0.039;135.0(77.6 ~240.0)mmHg vs 90.7(54.6 ~ 161.7) mmHg,P=0.023)].所有患儿收缩压、舒张压、心率在各时间点没有明显变化(P>0.05).存活组(n=9)与死亡组(n=14)相比,PaO2/FiO2、OI在H6、H12、H24、H48差异有统计学意义(P<0.05).非血液肿瘤组(n=10)与血液肿瘤组(n=13)相比,OI在H2、H6差异有统计学意义[19.2(13.9~26.6) vs 33.8(19.7 ~48.3),P=0.049;16.0(8.4~27.1) vs28.9(20.9 ~38.9),P=0.027)],两组的平均气道压在H2、H6、H12差异有统计学意义(P<0.05).两组病死率差异无统计学意义(40.0% vs 76.9%,P=0.086).结论 AHRF患儿给予CMV通气失败后改用HFOV可以改善患儿的PaO2和氧合指数,对患儿心率、血压没有明显影响.血液肿瘤伴AHRF组较非血液肿瘤伴AHRF组HFOV初始阶段需要较高的MAP改善氧合,但对病死率无影响.
目的 評估兒童急性低氧性呼吸衰竭(acute hypoxemic respiratory failure,AHRF)給予高頻振盪機械通氣(high-frequency oscillatory ventilation,HFOV)治療的意義.方法 迴顧2011年1月至2013年9月收入我院PICU診斷為AHRF的病例,首先給予常規機械通氣(CMV),噹PIP> 30cmH2O(1 cmH2O =0.098 kPa)或PEEP> 10 cmH2O、FiO2100%時具有以下情況之一:(1)SpO2 <90%或PaO2 <60 mmHg(1 mmHg =0.133 kPa);(2)有嚴重呼吸性痠中毒(PaCO2> 80mmHg);(3)嚴重氣漏(縱隔氣腫或氣胸),改為HFOV通氣治療.收集患兒性彆、年齡、住PICU時間、CMV通氣時間、HFOV通氣時間等一般資料.分彆于CMV通氣末(H0)及HFOV後2 h(H2)、6 h(H6)、12 h(H12)、24 h(H24)、48 h(H48)記錄併比較各時間點呼吸機參數(平均氣道壓、振幅、頻率、FiO2)、氧閤指數(PaO2/FiO2、OI)、動脈血氣、心率、血壓變化.分彆比較存活組與死亡組、血液腫瘤組及非血液腫瘤組在H0、H2、H6、H12、H24、H48時間點的指標變化.結果 HFOV通氣後,H2時間點PaO2較H0升高[76.9(61.9~128.0) mm-Hg vs 50.1 (49.5 ~ 68.0) mmHg],差異有統計學意義(P=0.006).H2、H48時間點PaO2/FiO2分彆較Ho、H24升高,差異有統計學意義[94.9(66.8 ~ 138.9) mmHg vs 68.0(49.5 ~ 86.8)mmHg,P=0.039;135.0(77.6 ~240.0)mmHg vs 90.7(54.6 ~ 161.7) mmHg,P=0.023)].所有患兒收縮壓、舒張壓、心率在各時間點沒有明顯變化(P>0.05).存活組(n=9)與死亡組(n=14)相比,PaO2/FiO2、OI在H6、H12、H24、H48差異有統計學意義(P<0.05).非血液腫瘤組(n=10)與血液腫瘤組(n=13)相比,OI在H2、H6差異有統計學意義[19.2(13.9~26.6) vs 33.8(19.7 ~48.3),P=0.049;16.0(8.4~27.1) vs28.9(20.9 ~38.9),P=0.027)],兩組的平均氣道壓在H2、H6、H12差異有統計學意義(P<0.05).兩組病死率差異無統計學意義(40.0% vs 76.9%,P=0.086).結論 AHRF患兒給予CMV通氣失敗後改用HFOV可以改善患兒的PaO2和氧閤指數,對患兒心率、血壓沒有明顯影響.血液腫瘤伴AHRF組較非血液腫瘤伴AHRF組HFOV初始階段需要較高的MAP改善氧閤,但對病死率無影響.
목적 평고인동급성저양성호흡쇠갈(acute hypoxemic respiratory failure,AHRF)급여고빈진탕궤계통기(high-frequency oscillatory ventilation,HFOV)치료적의의.방법 회고2011년1월지2013년9월수입아원PICU진단위AHRF적병례,수선급여상규궤계통기(CMV),당PIP> 30cmH2O(1 cmH2O =0.098 kPa)혹PEEP> 10 cmH2O、FiO2100%시구유이하정황지일:(1)SpO2 <90%혹PaO2 <60 mmHg(1 mmHg =0.133 kPa);(2)유엄중호흡성산중독(PaCO2> 80mmHg);(3)엄중기루(종격기종혹기흉),개위HFOV통기치료.수집환인성별、년령、주PICU시간、CMV통기시간、HFOV통기시간등일반자료.분별우CMV통기말(H0)급HFOV후2 h(H2)、6 h(H6)、12 h(H12)、24 h(H24)、48 h(H48)기록병비교각시간점호흡궤삼수(평균기도압、진폭、빈솔、FiO2)、양합지수(PaO2/FiO2、OI)、동맥혈기、심솔、혈압변화.분별비교존활조여사망조、혈액종류조급비혈액종류조재H0、H2、H6、H12、H24、H48시간점적지표변화.결과 HFOV통기후,H2시간점PaO2교H0승고[76.9(61.9~128.0) mm-Hg vs 50.1 (49.5 ~ 68.0) mmHg],차이유통계학의의(P=0.006).H2、H48시간점PaO2/FiO2분별교Ho、H24승고,차이유통계학의의[94.9(66.8 ~ 138.9) mmHg vs 68.0(49.5 ~ 86.8)mmHg,P=0.039;135.0(77.6 ~240.0)mmHg vs 90.7(54.6 ~ 161.7) mmHg,P=0.023)].소유환인수축압、서장압、심솔재각시간점몰유명현변화(P>0.05).존활조(n=9)여사망조(n=14)상비,PaO2/FiO2、OI재H6、H12、H24、H48차이유통계학의의(P<0.05).비혈액종류조(n=10)여혈액종류조(n=13)상비,OI재H2、H6차이유통계학의의[19.2(13.9~26.6) vs 33.8(19.7 ~48.3),P=0.049;16.0(8.4~27.1) vs28.9(20.9 ~38.9),P=0.027)],량조적평균기도압재H2、H6、H12차이유통계학의의(P<0.05).량조병사솔차이무통계학의의(40.0% vs 76.9%,P=0.086).결론 AHRF환인급여CMV통기실패후개용HFOV가이개선환인적PaO2화양합지수,대환인심솔、혈압몰유명현영향.혈액종류반AHRF조교비혈액종류반AHRF조HFOV초시계단수요교고적MAP개선양합,단대병사솔무영향.
Objective To evaluate the significance of high-frequency oscillatory ventilation(HFOV) used in acute hypoxic respiratory failure(AHRF) children,failing to conventional ventilation.Methods This was a retrospective study of AHRF children ventilated by HFOV from January 2011 to September,2013.All patients were initially treated by conventional mechanical ventilation (CMV),and changed to be treated by HFOV if the patient met to one of the following criteria after the CMV parameters of PIP > 30 mmH2O(1cmH2O =0.098 kPa) or PEEP > 10 cmH2O with FiO2 100% ∶ (1) SpO2 < 90% or PaO2 < 60 mmHg (1 mmHg =0.133 kPa) ; (2) severe respiratory acidosis (PaCO2 > 80 mmHg) ; (3) serious air leakage (mediastinal emphysema or pneumothorax).The following parameters were recorded:patient's gender,age,living PICU time,CMV ventilation time,HFOV ventilation time.We reviewed ventilation parameter settings (MAP,△P,F,FiO2),oxygenation index(PaO2/FiO2,OI),arterial blood gas,heart rate,blood pressure at different time points including late CMV(H0),2 h after HFOV(H2),6 h after HFOV(H6),12 h after HFOV(H12),24 h after HFOV (H24) and 48 h after HFOV (H48),respectively.Various indexes at different time points were compared between survival group and death group,oncology group and no-oncology group.Results PaO2 at H2 compared with H0 had significant improvement[76.9(61.9 ~ 128.0) mmHg vs 50.1 (49.5 ~68.0) mmHg,P =0.006] . PaO2/FiO2 at H2,H48 had significant improvement compared with those at H0,H24 [94.9(66.8 ~ 138.9) mmHg vs 68.0(49.5 ~86.8) mmHg,P=0.039; 135.0(77.6~240.0) mmHg vs 90.7 (54.6 ~161.7) mmHg,P =0.023)].All children's systolic pressure,diastolic blood pressure,heart rate at various time points had no difference (P >0.05).Compared to death group(n =14),PaO2/FiO2,OI at H6,H12,H24,H48 in survival group (n =9) had significant improvement(P < 0.05).Compared to oncology group (n =10),OI at H2,H6 in no-oncology group(n =10) had significant improvement [(19.2 (13.9 ~ 26.6) vs 33.8 (19.7 ~ 48.3),P =0.049 ; 16.0(8.4 ~27.1) vs 28.9(20.9 ~38.9),P =0.027)],and mean airway pressure between two groups at H2,H6,H12 had significant improvement(P < 0.05).Mortality had no significant differcence between two groups (4/10 vs 10/13,P =0.086).Conelusion HFOV used in children with AHRF which had failed with CMV ventilation can improve the patient's PaO2 and OI.Heart rate and blood pressure are stable during HFOV treatment.Oncology group patients needed higher initial MAP to improve oxygenation than no-oncology group patients when changed to HFOV treatment,but the mortality showed no difference between two groups.